狩野 俊樹

Successful Management of Critical Acute Respiratory Distress Syndrome following COVID-19 through Extracorporeal Membrane Oxygenation in a Patient with Concurrent Nephrotic Syndrome Relapse. 

Internal medicine (Tokyo, Japan) 62(21) 3209-3214 2023年11月1日  

The nucleotide-sensing Toll-Like Receptor 9/Toll-Like Receptor 7 system is a potential therapeutic target for IgA nephropathy. 

Kidney international 104(5) 943-955 2023年11月  

Outpatient clinic specific for end-stage renal disease improves patient survival rate after initiating dialysis. 

Scientific reports 13(1) 5991-5991 2023年4月12日  

Impact of anemia treatment for left ventricular hypertrophy using long-acting erythropoietin-stimulating agents from the pre-dialysis to maintenance dialysis period in patients with chronic kidney disease, retrospective longitudinal cohort study. 

BMC nephrology 24(1) 74-74 2023年3月25日  

Glomerular expression and urinary excretion of fatty acid-binding protein 4 in IgA nephropathy. 

Journal of nephrology 36(2) 385-395 2023年3月  

Serological and histopathological assessment of galactose-deficient immunoglobulin A1 deposition in kidney allografts: A multicenter prospective observational study. 

PloS one 18(2) e0281945 2023年  

Clinical Significance of the Intensity of Glomerular Galactose-Deficient IgA1 Deposition in IgA Nephropathy. 

Kidney international reports 7(12) 2726-2729 2022年12月  

Mucosal Immune System Dysregulation in the Pathogenesis of IgA Nephropathy. 

Biomedicines 10(12) 2022年11月24日  

Impact of Transferrin Saturation and Anemia on Radial Artery Calcification in Patients with End-Stage Kidney Disease. 

Nutrients 14(20) 2022年10月13日  

Glomerular deposition of galactose-deficient IgA1-containing immune complexes via glomerular endothelial cell injuries. 

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 37(9) 1629-1636 2022年8月22日  

Galactose-Deficient IgA1 as a Candidate Urinary Marker of IgA Nephropathy. 

Journal of clinical medicine 11(11) 2022年6月2日  

Molecular insights into the early stage of glomerular injury in IgA nephropathy using single-cell RNA sequencing. 

Kidney international 101(4) 752-765 2022年4月  

Negative-pressure wound therapy is effective for peritoneal dialysis catheter exit-site management in the early postoperative period. 

Scientific reports 12(1) 70-70 2022年1月7日  

Nasal-associated lymphoid tissue is the major induction site for nephritogenic IgA in murine IgA nephropathy. 

Kidney international 100(2) 364-376 2021年8月  

Renal pathological analysis using galactose-deficient IgA1-specific monoclonal antibody is a strong tool for differentiation of primary IgA nephropathy from secondary IgA nephropathy. 

CEN case reports 10(1) 17-22 2021年2月  

TLR9 activation induces aberrant IgA glycosylation via APRIL- and IL-6-mediated pathways in IgA nephropathy. 

Kidney international 97(2) 340-349 2020年2月  

A Proliferation Inducing Ligand (APRIL) targeted antibody is a safe and effective treatment of murine IgA nephropathy. 

Kidney international 96(1) 104-116 2019年7月  

IgA nephropathy and IgA vasculitis with nephritis have a shared feature involving galactose-deficient IgA1-oriented pathogenesis. 

Kidney international 93(3) 700-705 2018年3月  

[The possibility of a kidney-gut axis based on dysregulation of the mucosal immune response]. 

Nihon Jinzo Gakkai shi 59(4) 552-556 2017年